Do CD4+ T Cell Responses to Epstein–Barr Virus Protect Against CNS Lymphoma in AIDS?
Author Information
Author(s): Mark A. Jacobson
Primary Institution: University of California San Francisco, San Francisco General Hospital
Hypothesis
Does an EBV antigen-specific T cell response provide protective immunity that is lost in AIDS-related primary CNS lymphoma?
Conclusion
The study suggests that EBV-specific CD4+ T cell function is lacking in AIDS patients who develop primary CNS lymphoma.
Supporting Evidence
- Patients with AIDS-related primary CNS lymphoma often have advanced disease.
- EBV infection is linked to the pathogenesis of primary CNS lymphoma.
- HAART improves immune function but its effect on EBV-specific T cell responses is mixed.
Takeaway
The study looked at whether certain immune cells can protect people with AIDS from a type of brain cancer, but found that these protective cells were missing in those who got sick.
Methodology
A case-control study measured EBV-specific CD4+ T cell responses in patients diagnosed with primary CNS lymphoma compared to matched controls.
Limitations
The study had a small sample size and did not measure EBV-specific CD8+ T cell function or T/B cell activation.
Participant Demographics
Six patients with primary CNS lymphoma and 16 matched HIV-positive controls.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website